Arcus Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Operational HighlightsBusiness Wire • 02/24/21
Arcus Biosciences Presents Promising Initial Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic CancerBusiness Wire • 01/15/21
Arcus Biosciences to Present Preliminary Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer at ASCO-GI SymposiumBusiness Wire • 01/11/21
Arcus Biosciences Appoints Biotech Industry Veteran, Andrew Perlman, M.D., Ph.D. and Gilead's SVP of Research Biology, Michael Quigley, Ph.D.Business Wire • 01/06/21
Are Options Traders Betting on a Big Move in Arcus Biosciences (RCUS) Stock?Zacks Investment Research • 01/04/21
Arcus Biosciences Expands Strategic Relationship with WuXi Biologics to Develop a Best-in-Class anti-CD39 Antibody for the Treatment of CancerBusiness Wire • 12/10/20
Arcus Biosciences to Participate in the Evercore ISI 3rd Annual HealthCONx Virtual ConferenceBusiness Wire • 11/18/20
Arcus Biosciences Announces Third Quarter 2020 Financial Results and Corporate UpdatesBusiness Wire • 11/05/20
Arcus to Collaborate With AstraZeneca on Registrational Trial for Domvanalimab, Arcus's Novel Anti-TIGIT Antibody, Plus Imfinzi® in Stage III NSCLCBusiness Wire • 10/29/20
Arcus Biosciences to Participate in Upcoming September 2020 Investor ConferencesBusiness Wire • 08/27/20
Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate UpdatesBusiness Wire • 08/06/20
Arcus Biosciences, Inc. (RCUS) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/28/20
Gilead Sciences and Arcus Biosciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer ImmunotherapiesBusiness Wire • 07/13/20
Has Arcus Biosciences (RCUS) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 06/29/20
Is Arcus Biosciences (RCUS) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 06/12/20